A British-Swedish multinational pharmaceutical and biopharmaceutical company


AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation.


AstraZeneca was formed on 6 April 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK – two companies with similar science-based cultures and a shared vision of the pharmaceutical industry.

The merger aimed to improve the combined companies’ ability to deliver long term growth and enduring shareholder value through:


Our commitment to making a meaningful difference to patient health is founded on innovative science.


AstraZeneca’s mission is to create a meaningful difference in the lives of the patients we serve and the people who work here.